Biomarkers of clinical benefit for anti-epidermal growth factor receptor agents in patients with non-small-cell lung cancer

Por Pallis, A G, Fennell, D A, Szutowicz, E, Leighl, N B, Greillier, L, Dziadziuszko, R
Publicado em 2011

Small Cell Ovarian Cancer in Adolescents: Report of Two Cases and Review of the Literature

Por Rovithi, M., Pallis, A. G., Kalykaki, A., Lagoudaki, E., Giannikaki, L., Stathopoulos, E. N., Relakis, K., Georgoulias, V.
Publicado em 2011

Clinical relevance of circulating CK-19mRNA-positive tumour cells before front-line treatment in patients with metastatic breast cancer

Por Androulakis, N, Agelaki, S, Perraki, M, Apostolaki, S, Bozionelou, V, Pallis, A, Kalbakis, K, Xyrafas, A, Mavroudis, D, Georgoulias, V
Publicado em 2012

‘Classical’ but not ‘other’ mutations of EGFR kinase domain are associated with clinical outcome in gefitinib-treated patients with non-small cell lung cancer

Por Pallis, A G, Voutsina, A, Kalikaki, Ar, Souglakos, J, Briasoulis, E, Murray, S, Koutsopoulos, A, Tripaki, M, Stathopoulos, E, Mavroudis, D, Georgoulias, V
Publicado em 2007

International validation of the EORTC QLQ-ELD14 questionnaire for assessment of health-related quality of life elderly patients with cancer

Por Wheelwright, S, Darlington, A-S, Fitzsimmons, D, Fayers, P, Arraras, J I, Bonnetain, F, Brain, E, Bredart, A, Chie, W-C, Giesinger, J, Hammerlid, E, O'Connor, S J, Oerlemans, S, Pallis, A, Reed, M, Singhal, N, Vassiliou, V, Young, T, Johnson, C
Publicado em 2013